Xinli Liu

Pharmacological and Pharmaceutical Sciences, University of Houston

Research Area

Biography

Xinli Liu has not added Biography.
If you are Xinli Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Enhanced capture and release of circulating tumor cells using hollow glass microspheres with a nanostructured surface. Nanoscale\| PubMed ID: 30160287	2018
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. The Annals of pharmacotherapy\| PubMed ID: 30522347	2019
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery. Frontiers in pharmacology\| PubMed ID: 30914953	2019
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment. Seminars in cancer biology\| PubMed ID: 31874280	2021
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus. Antimicrobial agents and chemotherapy\| PubMed ID: 33361306	2021
Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology\| PubMed ID: 33470550	2021
Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation. mBio\| PubMed ID: 33653893	2021
Thermosensitive Biodegradable Copper Sulfide Nanoparticles for Real-Time Multispectral Optoacoustic Tomography. ACS applied bio materials\| PubMed ID: 33907729	2019
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature\| PubMed ID: 34082438	2021
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma. Blood advances\| PubMed ID: 34357379	2021
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2. iScience\| PubMed ID: 34462731	2021
Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils. Biomaterials science\| PubMed ID: 34994371	2022
Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging. Biochemical pharmacology\| PubMed ID: 35561842	2022
The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis. Neoplasia (New York, N.Y.)\| PubMed ID: 35839699	2022
Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model. The Journal of antimicrobial chemotherapy\| PubMed ID: 37563789	2023
MALDI Imaging Mass Spectrometry Visualizes the Distribution of Antidepressant Duloxetine and Its Major Metabolites in Mouse Brain, Liver, Kidney, and Spleen Tissues. Drug metabolism and disposition: the biological fate of chemicals\| PubMed ID: 38658163	2024
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models. Nature communications\| PubMed ID: 39025863	2024
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters. Nature communications\| PubMed ID: 39043645	2024
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. Journal for immunotherapy of cancer\| PubMed ID: 39313308	2024
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer. British journal of pharmacology\| PubMed ID: 39965212	2025
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses. Nature communications\| PubMed ID: 40301359	2025
Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity. Antimicrobial agents and chemotherapy\| PubMed ID: 40626888	2025
Comparative effectiveness and safety of glatopa and copaxone in patients with multiple sclerosis. Multiple sclerosis and related disorders\| PubMed ID: 40975020	2025